News
Golden Compass expands Portfolio of Australian Based Tour Leaders
www.newsmaker.com.au
Golden Compass expands Portfolio of Australian Based Tour Leaders
Exonate Closes Successful Funding Round - To Develop Eye Drops...
www.informazione.it
- Early stage biotechnology company targeting ophthalmology and other areas of unmet medical need
ARVO 2018, Honolulu
www.exonate.com
David is available for meetings whilst there and contact can be made via Louise Shave · Visit event website ...
Exonate Receives Wellcome Trust Funding to Develop Eye Drop Treatment...
www.informazione.it
Exonate, an early stage biotechnology company has been awarded a £4.9m Seeding Drug Discovery award by the Wellcome Trust to continue development of an…
sorted by relevance / date